產(chǎn)品詳情
簡單介紹：
Anti-phospho-CK8 (Ser23)抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-phospho-CK8 (Ser23)抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-phospho-CK8 (Ser23)
Cat. Number:
Anti-phospho-CK8 (Ser23)抗體KL-3743R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is a member of theAnti-phospho-CK8 (Ser23)抗體 type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012].
Also known as:
Cytokeratin 8 (phospho S23); Anti-phospho-CK8 (Ser23)抗體p-Cytokeratin 8 (phospho S23); card2; Cardiac autoantigen 2 120kD; CK 8; CK-8; ck8; Cyk 8; cyk8; CYKER; Cytokeratin 8; Cytokeratin endo A; Cytokeratin-8; Cytokeratin8; DreK8; EndoA; k0; CYK8; k2c8; K2C8_HUMAN; k8; Keratin 8; Keratin type ii cytoskeletal 8; Keratin, type II cytoskeletal 8; Keratin-8; Keratin8; KO; Krt 2.8; Krt 8; krt8; KRT-8; MGC118110; MGC174782; MGC53564; MGC85764; sb:cb186; Type-II keratin Kb8.
Specificity:
●
Rabbit Polyclonal IgG, affinityAnti-phospho-CK8 (Ser23)抗體 purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human CK8 around the phosphorylation site of Ser23.
●
Predicted Molecular Weight: 53kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-phospho-CK8 (Ser23)抗體(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl130Rb51 組織金屬蛋白酶抑制因子4(TIMP4)多克隆抗體 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)
kl131Bo01 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Fi01 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Hu01 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Mu01 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Po01 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Rb51 轉(zhuǎn)化生長因子β誘導蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl132Hu01 脂聯(lián)素受體2(ADIPOR2)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)
kl132Ra01 脂聯(lián)素受體2(ADIPOR2)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)
kl134Bo01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ca01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Hu01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Mu01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Po01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ra01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Rb51 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
